e-SPACE Cardio-Renal-Metabolic 2022: On-demand

Published: 11 April 2022

  • Views:

    Views Icon 20283
  • Likes:

    Heart Icon 7
  • episode_image
    1m 29s
    Part 4 | Session 1 Introduction Vijay Chopra, Marco Metra
  • episode_image
    1m 9s
    Part 6 | Session 1 Introduction Andrew JS Coats, Alice Cheng
  • episode_image
    1m
    Part 11 | Session 1 Introduction Mustafa Arici, Pardeep Jhund
  • episode_image
    1m 15s
    Part 13 | Session 1 Introduction Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    8m 55s
    Part 13 | Session 3 6.2: Preserved HF Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    24m 16s
    Part 13 | Session 6 Panel discussion Fausto J Pinto, Clara Saldarriaga, Stefan Anker
  • episode_image
    31m 48s
    Part 16 | Session 5 Panel discussion Stefan Anker, Stephan Von Haehling
  • episode_image
    2m 7s
    Part 22 | Session 1 Introduction Piotr Ponikowski, Muthiah Vaduganathan
  • episode_image
    24m 22s
    Part 22 | Session 6 Panel discussion Piotr Ponikowski, Muthiah Vaduganathan
  • episode_image
    50s
    Part 24 | Session 1 Introduction Stefan Anker, Linda Mellbin
  • episode_image
    2m 39s
    Part 27 | Session 1 Introduction Hiddo Lambers Heerspink
  • episode_image
    1m 23s
    Part 29 | Session 1 Introduction Martin R Cowie, Harriette Van Spall
  • episode_image
    34m 11s
    Part 29 | Session 4 Panel discussion Martin R Cowie, Harriette Van Spall
  • episode_image
    1m 50s
    Part 32 | Session 1 Introduction Melanie Davies, Julio Rosenstock, Nikolaus Marx
Average (ratings)
No ratings
Your rating

Overview

e-SPACE CARDIO-RENAL-METABOLIC 2022, held on 4-6 March 2022, was the second edition of the global online conference on cardio renal metabolic diseases.

 

The organisers, under the direction of a world-renowned scientific committee, brought together leading experts in cardiology, nephrology, and diabetology to share clinical practice strategies in treating the inter-related diseases now affecting hundreds of millions people worldwide.

 

This on-demand version of the event comprises:

 

  • Presentations and discussions with leading experts
  • Evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity
  • Insight to SLGT2i, GLP-1RA and other emerging therapies
  • 'Meet the Expert' sessions

 

e-SPACE Cardio-Renal-Metabolic 2022 was supported by the following companies:

More from this programme

Part 1

Meet the Expert: IgA nephropathy: current optimal management

Part 3

Industry Session: Iron deficiency in heart failure and kidney disease: interdisciplinary crosstalk

Part 5

Meet the Experts: NAFLD/NASH as a metabolic disease: improving patients outcomes

Part 7

Meet the Experts: The meaning of Hemoglobin A1C for the nephrologist and the cardiologist

Part 12

Meet the Experts: CV, mortality & kidney outcomes with GLP-1 AR in patients with T2DM

Part 14

Meet the Experts: The HF Diabetic patient with CKD: optimizing care for a high-risk group

Part 17

Meet the Expert: HIF PHI: What do we know and don't know in 2022

Part 19

Industry Session: SGLT2 inhibition in the comorbid CKD patient

Satellite Symposium supported by an unrestricted educational grant from AstraZeneca

Part 21

Meet the Expert: SGLT2 inhibitors in heart failure: Improving outcomes across the spectrum of the disease

Part 23

Meet the Expert: The meaning of eGFR for the cardiologists and diabetologist

Part 25

Meet the Experts: Personalized care of patients with heart failure: hyperkalemia as a barrier to optimal medical therapy

Part 26

Meet the Expert: SGLT2, the statin of the 21st century

Part 28

Meet the Experts: Reducing the risk of cardiovascular events for patients with CKD and T2DM: new treatment options

Part 31

Meet the Expert: Management of worsening HF

Part 32

Session 16: Harmonising the gluco-and cardio-centric management of diabetes

Faculty Biographies

Melanie Davies

Melanie Davies

Director of the Leicester NIHR Biomedical Research Centre, Leicester, UK

Prof Melanie Davies is Director of the Leicester NIHR Biomedical Research Centre, Director of the Patient Recruitment Centre Leicester and a Professor in Diabetes Medicine at the University of Leicester, UK. She has published over 500 original articles in leading journals.

Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus. She has served as the PI for a number of large global studies in diabetes, obesity, sedentary behaviour and cardiovascular disease. In 2016 she was the recipient of a CBE for services to diabetes research.

View full profile
Julio Rosenstock

Julio Rosenstock

Director of the Dallas Diabetes Research Center at Medical City, and Clinical Professor of Medicine

Dr Julio Rosenstock is Director of the Dallas Diabetes Research Center at Medical City, and Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas.

Dr Rosenstock obtained his MD from the University of Costa Rica School of Medicine with fellowships in Endocrinology and Diabetes at the Royal Postgraduate Medical School, Hammersmith Hospital, London, UK, and University of Texas Southwestern Medical Center.

View full profile
Nikolaus Marx

Nikolaus Marx

Professor of Medicine

Prof Nikolaus Marx is a Professor of Medicine / Cardiology at RWTH University Hospital Aachen, Aachen, DE.

Prof Marx's interests include cardiovascular disease in patients with comorbidities including diabetes and chronic kidney disease.

View full profile